Brian Gallagher

Brian Gallagher

Director/Miembro de la Junta en
Nimbus Apollo, Inc.
.
56 años
Health Technology
Finance
Consumer Services

Perfil

Brian M.
Gallagher
's current jobs include being a Director at eFFECTOR Therapeutics Operations, Inc., Nimbus Apollo, Inc., and Slate Bio, Inc. Formerly, Dr. Gallagher served as the Chairman at eFFECTOR Therapeutics, Inc. from 2021 to 2024.
He was also a Director at CalciMedica Subsidiary, Inc. from 2013 to 2018, Aileron Therapeutics, Inc. from 2010 to 2018, Nimbus Therapeutics LLC from 2011 to 2018, Translate Bio, Inc. from 2011 to 2019, River Vision Development Corp.
from 2012 to 2017, Navitor Pharmaceuticals, Inc. from 2014 to 2018, and GSK Equity Investments Ltd. from 2010 to 2018.
Additionally, he held positions as a Director at Dicerna Pharmaceuticals, Inc., SpringLeaf Therapeutics, Inc., and Constellation Pharmaceuticals, Inc. Dr. Gallagher's education includes graduate and doctorate degrees from the University of Michigan.

Cargos activos de Brian Gallagher

EmpresasCargoInicio
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -

Antiguos cargos conocidos de Brian Gallagher.

EmpresasCargoFin
EFFECTOR THERAPEUTICS, INC. Presidente 21/06/2024
Director/Miembro de la Junta 31/12/2022
Inversor de Capital Privado 01/01/2022
TRANSLATE BIO, INC. Director/Miembro de la Junta 01/01/2019
REIN THERAPEUTICS INC. Director/Miembro de la Junta 19/03/2018
Ver el detalle de la experiencia de Brian Gallagher.

Formación de Brian Gallagher.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

60

Relaciones de 1er grado

21

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas21

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology